Comparing two approaches for treating chronic shoulder pain with nerve modulation
Comparison of Spinoglenoid and Suprascapular Notch Approaches and Neuromodulation of the Suprascapular Nerve Under Ultrasonography Guided in Shoulder Pain
Kanuni Sultan Suleyman Training and Research Hospital · NCT06852781
This study is testing two different methods for treating chronic shoulder pain by targeting a specific nerve to see which one works better for adults who still have pain after other treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06852781 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of two different approaches, the Spinoglenoid and Suprascapular Notch techniques, for neuromodulation of the suprascapular nerve in patients suffering from chronic shoulder pain. Patients over 18 years old with persistent pain despite previous treatments will be retrospectively analyzed based on their medical records. The study will assess various factors including age, gender, pain duration, and treatment response to determine the efficacy of the procedures under ultrasound guidance. The aim is to provide insights into pain management strategies for chronic shoulder conditions.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with chronic shoulder pain lasting more than 3 months who have not found relief from standard treatments.
Not a fit: Patients with recent shoulder injections, malignancies, or certain medical conditions such as inflammatory arthritis or major psychopathology may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and quality of life for patients with chronic shoulder pain.
How similar studies have performed: While similar approaches have been explored, this specific comparison of techniques for chronic shoulder pain management is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over the age of 18 who have pain at or above visual analog scale (VAS) 4 despite pharmacological agents and physical therapy (passive range of motion, strengthening exercises) for more than 3 months and who meet the inclusion criteria will be included in the study. * Patients with complete data to be scanned in their files Exclusion Criteria: * Patients with known malignancy, * patients who had shoulder injections within the last 3 months, * patients who changed their medical analgesic treatment or underwent surgery during follow-up, * patients with previous shoulder surgery or deformity, * patients with inflammatory arthritis and fibromyalgia, * patients with known cervical disc herniation, * patients with pacemakers, pregnant women, * patients with chronic decompensated disease, * hemiplegic patients, * patients with major psychopathology, * patients allergic to medications used during the procedure, * patients with infection in the procedure area, * patients with bleeding disorders, and patients who did not agree to participate in the study were excluded from the study.
Where this trial is running
Istanbul
- Kanuni Sultan Süleyman Training and Research Hospital — Istanbul, Turkey (RECRUITING)
Study contacts
- Study coordinator: halil ibrahim altun, specialist
- Email: halilibrahim_altun@yahoo.com
- Phone: +905072774773
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Shoulder Pain Chronic, Neuromodulation, Ultrasound Guided